Business Description
Pharmena SA
ISIN : PLPHRMN00011
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 122.86 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.01 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 27.75 | |||||
Beneish M-Score | -4.64 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.7 | |||||
3-Year EPS without NRI Growth Rate | 35.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.91 | |||||
9-Day RSI | 29.8 | |||||
14-Day RSI | 31.47 | |||||
6-1 Month Momentum % | 24.57 | |||||
12-1 Month Momentum % | 6.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.17 | |||||
Quick Ratio | 12.92 | |||||
Cash Ratio | 12.56 | |||||
Days Inventory | 200.38 | |||||
Days Sales Outstanding | 92.13 | |||||
Days Payable | 1216.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 13.2 | |||||
Forward Dividend Yield % | 13.2 | |||||
5-Year Yield-on-Cost % | 13.2 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 16.96 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.4 | |||||
Operating Margin % | -22.75 | |||||
Net Margin % | 294.21 | |||||
FCF Margin % | 332.6 | |||||
ROE % | 573.07 | |||||
ROA % | 113.15 | |||||
ROIC % | -23.83 | |||||
ROC (Joel Greenblatt) % | 8789.17 | |||||
ROCE % | 591.41 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2.4 | |||||
Price-to-Owner-Earnings | 2.31 | |||||
PS Ratio | 7.02 | |||||
PB Ratio | 3.06 | |||||
Price-to-Tangible-Book | 3.08 | |||||
Price-to-Free-Cash-Flow | 2.11 | |||||
Price-to-Operating-Cash-Flow | 2.09 | |||||
EV-to-EBIT | 1.33 | |||||
EV-to-EBITDA | 1.32 | |||||
EV-to-Revenue | 4.78 | |||||
EV-to-FCF | 1.54 | |||||
Price-to-Projected-FCF | 1.46 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Price-to-Net-Current-Asset-Value | 3.18 | |||||
Price-to-Net-Cash | 3.35 | |||||
Earnings Yield (Greenblatt) % | 74.9 | |||||
FCF Yield % | 47.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmena SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 9.837 | ||
EPS (TTM) (zł) | 2.59 | ||
Beta | 0.71 | ||
Volatility % | 36.85 | ||
14-Day RSI | 31.47 | ||
14-Day ATR (zł) | 0.280076 | ||
20-Day SMA (zł) | 6.571 | ||
12-1 Month Momentum % | 6.82 | ||
52-Week Range (zł) | 5.3 - 9.18 | ||
Shares Outstanding (Mil) | 11.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmena SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmena SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Pharmena SA Frequently Asked Questions
What is Pharmena SA(WAR:PHR)'s stock price today?
When is next earnings date of Pharmena SA(WAR:PHR)?
Does Pharmena SA(WAR:PHR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |